FRAME and the Pharmaceutical Industry

Rowan A.N. , and Stratmann C.J. eds. (1980). The Use of Alternatives in Drug Research, 190 pp. London: Macmillan.

Balls M. , and Fentem J.H. (1994). The Fund for the Replacement of Animals in Medical Experiments (FRAME): 23 years of campaigning for the Three Rs. In Alternatives to Animal Testing: New Ways in the Biomedical Sciences, Trends and Progress (ed. Reinhardt C.A. ), pp. 45–55. Weinheim, Germany: VCH.

Balls M. (1995). Defining the role of ECVAM in the development, validation and acceptance of alternative tests and testing strategies. Toxicology in Vitro 9, 863–869.

Anon. (1994). Animal Procedures Committee: Report to the Home Secretary on Regulatory Toxicity, 20 pp. London: Home Office Publications.

Anon. (1996). The first 10 years of the Animals (Scientific Procedures) Act 1986. ATLA 24, 639–647.

Balls M. , Riddell R.J. , and Worden A.N. eds (1983). Animals and Alternatives in Toxicity Testing, 550 pp. London & New York: Academic Press.

Balls M. , Bridges J. , and Southee J. eds (1991). Animals and Alternatives in Toxicology: Present Status and Future Prospects, 390 pp. Basingstoke, UK: Macmillan.

Clothier R.H. , Atkinson K.A. , Garle M.J. , Ward R.K. , and Willshaw A. (1995). The development and evaluation of in vitro tests by the FRAME Alternatives Laboratory. ATLA 23, 75–90.

Hammond A.H. , and Fry J.R. (1994). Toxicity of precocene II in rat hepatocyte cultures: effects of serum and culture time. Toxicology Letters 70, 337–342.

Marchant C.A. , and Combes R.D. (1996). Artificial intelligence: the use of computer methods in the prediction of metabolism and toxicity. In Bioactive Compounds: Possibilities for Industrial Use (ed. Ford M.G. , Greenwood R. , Brooks G.T. , Franke R. ), pp. 153–162. Oxford, UK: Bioscientific Publishers Ltd.

Morton D.B. , Abbot D. , Barclay R. , Close B.S. , Ewbank R. , Gask D. , Heath M. , Mattic S. , Poole T. , Seamer J. , Southee J. , Thompson A. , Trussell B. , West C. , and Jennings M. (1993). Removal of blood from laboratory mammals and birds. First report of the BVA/FRAME/RSPCA/UFAW Joint Working Group on Refinement. Laboratory Animals 27, 1–22.

Morton D.B. , Jennings M. , Batchelor G.R. , Bell D. , Birke L. , Davies K. , Eveleigh J.R. , Gunn D. , Heath M. , Howard B. , Koder P. , Phillips J. , Poole T. , Sainsbury A.W. , Sales G.D. , Smith D.J.A. , Stauffacher M. , and Turner R.J. (1993). Refinements in rabbit husbandry. Second report of the BUAAWF/FRAME/RSPCA/UFAW Joint Working Group on Refinement. Laboratory Animals 27, 301–329.

Garthoff B. (1995). Alternative testing in drug research and development: the validation issue. Toxicology in Vitro 9, 789–793.

Castell J.V. , & Gómez-Lechón M.J. (1996). In Vitro Methods in Pharmaceutical Research, 467 pp. London: Academic Press.

Martin E.J. , Blaney J.M. , Siani M.A. , Spellmeyer D.C. , Wong A.K. , and Moos W.H. (1995). Measuring diversity: experimental design of combinatorial libraries for drug discovery. Journal of Medicinal Chemistry 38, 143–146.

Gómez-Lechón M.J. (1995). In vitro assays in the development of drugs and chemicals. In ICLAS/CSIC Working Group on Complementary Methods (ed. de la Pena E. ), pp. 59–66. Comite Espanol del ICLAS/CICYT/CSIC.

Leung H-W. (1993). Physiologically-based pharmacokinetic modelling. In General and Applied Toxicology, Vol. I (ed. Ballantyne B. , Marrs T. , Turner P. ), pp. 153–164. Basingstoke, UK: Macmillan.

van Ommen B. , de Jongh J. , van de Sandt J. , Blaauboer B. , Hissink E. , Bogaards J. , & van Bladeren P. (1995). Computer-aided biokinetic modelling combined with in vitro data. Toxicology in Vitro 9, 53–54.

Balls M. , Goldberg A.M. , Fentem J.H. , Broad-head C.L. , Burch R.L. , Festing M.F.W. , Frazier J.M. , Hendriksen C.F.M. , Jennings M. , van der Kamp M.D.O. , Morton D.B. , Rowan A.N. , Russell C. , Russell W.M.S. , Spielmann H. , Stephens M.L. , Stokes W.S. , Straughan D.W. , Yager J.D. , Zurlo J. , & van Zutphen B.F.M. (1995). The Three Rs: the way forward. The report and recommendations of ECVAM workshop 11. ATLA 23, 838–866.

Tweats D. , and Scales D. (1994). Progress with harmonisation of guidelines for human pharmaceuticals. Toxicology and Ecotoxicology News 1, 113–116.

Ashby J.A. (1996). Alternatives to the 2-species bioassay for the identification of potential human carcinogens. Human and Experimental Toxicology 15, 183–202.

Anon. (1993). Resolution of the Council and the Representatives of the Governments of the Member States, meeting within the Council of 1 February 1993, on a Community programme of policy and action in relation to the environment and sustainable development. Official Journal of the European Communities C138, 1–98.

Straughan D.W. (1995). The EU target for a 50% reduction in use of experimental animals by the year 2000: what does it mean? ATLA 23, 262–263.

Acred P. , Hennessey T.D. , MacArthur-Clark J.A. , Merrikin D.J. , Ryan D.M. , Smulders H.C. , Troke P.F. , Wilson R.G. , and Straughan D.W. (1994). Guidelines for the welfare of animals in rodent protection tests: a report from the Rodent Protection Test Working Party. Laboratory Animals 28, 13–18.

Morton D.B. (1995). Advances in refinement in animal experimentation over the past 25 years. ATLA 23, 812–822.

Balls M. , Fentem J. , and Joint E. (1992). Issues: Animal Experiments, 16 pp. Cambridge, UK: Hobsons.

Fentem J.H. , Balls M. , and Robinson P. (1993). Developing Alternatives to Animal Experimentation, 19 pp. Cambridge, UK: Hobsons.

Hampson J. , Southee J. , Howell D. , and Balls M. (1990). An RSPCA/FRAME survey on the use of non-human primates as laboratory animals in Great Britain 1984–1988. ATLA 17, 335–400.